Figure 4From: A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatmentCumulative incidence of metachronous contralateral breast cancer in women with (····) and in those without (--) germline BRCA mutations (P < 0.0001).Back to article page